Evoke Pharma Plunges After FDA Issues CRL for Gimotti

Evoke Pharma Plunges After FDA Issues CRL for Gimotti

Source: 
BioSpace
snippet: 

The CRL is not totally unexpected, given that last month the company received a multi-disciplinary review (DR) letter from the FDA regarding its New Drug Application.